Simultaneous quantification of oestrogens and androgens in the serum of patients with benign prostatic hyperplasia by liquid chromatography-Tandem mass spectrometry.
Tingting YangYuhan HuangYi ZhouShangxiu ChenHaiyan WangYinlu HuJunjie LiuZhenzhou JiangQian LuXiaoxing YinPublished in: Andrologia (2020)
Benign prostate hyperplasia (BPH) is a common disease in elderly men. It has been found that the occurrence of BPH was closely related to dysregulated steroid hormones. Here, a rapid, sensitive, accurate and specific method for the quantitative profiling of five androgens in man serum was developed and validated by the use of liquid chromatography-tandem mass spectrometry (LC-MS/MS). Using this method, dehydroepiandrosterone (DHEA), androstenedione (A4), testosterone (T), androsterone (A), dihydrotestosterone (DHT), oestrone (E1) and oestradiol (E2) were quantified in serum from man with and without BPH. BPH patients were characterised by the decreases in DHEA, A4 and T as well as increases in DHT, E2 and E1 in serum. Meanwhile, DHEA and DHT in serum were screened as sensitive biomarkers of BPH patients. This study will provide a new perspective of dysregulated steroid hormones for the diagnosis and prevention of BPH.
Keyphrases
- benign prostatic hyperplasia
- lower urinary tract symptoms
- liquid chromatography tandem mass spectrometry
- end stage renal disease
- ejection fraction
- simultaneous determination
- chronic kidney disease
- newly diagnosed
- prostate cancer
- ms ms
- peritoneal dialysis
- middle aged
- mass spectrometry
- patient reported outcomes
- risk assessment
- replacement therapy